Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
NONO Logo
NONO Growth Score
13
CB Rank
292502
Heat Score
13
NoNO is engaged in the development of pharmaceuticals for the treatment of common health disorders.
Founded
obfuscation
PrivatePrivate Equity Toronto, Ontario, Canada11-50 www.nonoinc.ca
Biotechnology
Health Care
Health Diagnostics
Medical
Overview

NONO
Total Funding
obfuscation
Growth Score
13
Heat Score
13

Total Funding
obfuscation
obfuscation
Private Equity raised
obfuscation
Growth Score13
1 pts
in past quarter
Heat Score 13
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About NONO

CB Rank
292502
NoNO is engaged in the development of pharmaceuticals for the treatment of common health disorders.
Founded
obfuscation
PrivatePrivate Equity Toronto, Ontario, Canada11-50 www.nonoinc.ca
Biotechnology
Health Care
Health Diagnostics
Medical

Funding Rounds

Private Equity
OBF
in
obfuscation
Venture - Series Unknown
OBF
in
obfuscation

Key People

Details

Legal Name NONO Inc.
Operating Status Active
Company Type For Profit
Founders  Michael Tymianski, Michael W. Salter
About the Company
NoNO Inc. is a private, clinical-stage biotherapeutics company dedicated to the research, development and commercialization of pharmaceuticals for the treatment of common health disorders with unmet needs, including stroke, traumatic brain injury, and pain.
Phone Number 4166035505
Contact Email info@nonoinc.ca
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Nerinetide
A 20 amino acid peptide administered intravenously to improve outcomes after acute ischemic stroke by protecting brain cells and reducing damage.
NoNO-42
A next-generation PSD-95 inhibitor in Phase 1 trials for acute ischemic stroke, designed to be effective with or without thrombolytic treatment.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Private Equity Round - NONO Logo
Private Equity Round - NONO
—
obfuscation
— Private Equity
obfuscation
Private Equity Round - NONO Logo
Private Equity Round - NONO
—
obfuscation
— Private Equity
obfuscation
Private Equity Round - NONO Logo
Private Equity Round - NONO
—
obfuscation
— Private Equity
obfuscation
Private Equity Round - NONO Logo
Private Equity Round - NONO
—
obfuscation
— Private Equity
obfuscation
Private Equity Round - NONO Logo
Private Equity Round - NONO
—
obfuscation
— Private Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Private Equity Round - NONO Logo
Private Equity Round - NONO
—
obfuscation
— Private Equity
obfuscation
Private Equity Round - NONO Logo
Private Equity Round - NONO
—
obfuscation
— Private Equity
obfuscation
Private Equity Round - NONO Logo
Private Equity Round - NONO
—
obfuscation
— Private Equity
obfuscation
Private Equity Round - NONO Logo
Private Equity Round - NONO
—
obfuscation
— Private Equity
obfuscation
Private Equity Round - NONO Logo
Private Equity Round - NONO
—
obfuscation
— Private Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
BlueSky Capital Logo
BlueSky Capital
—
Venture Round - NONO Logo
Venture Round - NONO
—
BlueSky Capital Logo
BlueSky Capital
—
Venture Round - NONO Logo
Venture Round - NONO
—
BlueSky Capital Logo
BlueSky Capital
—
Venture Round - NONO Logo
Venture Round - NONO
—
BlueSky Capital Logo
BlueSky Capital
—
Venture Round - NONO Logo
Venture Round - NONO
—
BlueSky Capital Logo
BlueSky Capital
—
Venture Round - NONO Logo
Venture Round - NONO
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 2 Board Members and Advisors 1 Contacts 27

Employee Profiles

Board Members and Advisors

News
Technology
View Tech Report

Monthly Web Visits

502
83.88%
 in past month

IT Spend

$91KThis year, NONO is projected to spend $91K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Graphic Design Logo
Graphic Design
94
Indicative Pricing Logo
Indicative Pricing
93
Apple iPad Logo
Apple iPad
87

Actively Used Products

9NONO uses 9 technology products and services including HTML5, Lightbox, and  Google Tag Manager, according to G2 Stack.

Active Website Tech Count

3NONO is actively using 3 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m and  Euro.

Total IP

60The intellectual property of NONO includes 56 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, NONO has registered 4 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is NONO's headquarters? NONO is located in Toronto, Ontario, Canada.Who invested in NONO? NONO is funded by BlueSky Capital.When was the last funding round for NONO? NONO closed its last funding round on
obfuscation
from a Private Equity round.Who are NONO's competitors? Alternatives and possible competitors to NONO may include Roche, AstraZeneca, and  Bayer.How much funding has NONO raised to date? NONO has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|